Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
65,210,419
-
Share change
-
+1,505,291
-
Total reported value
-
$202,829,241
-
Put/Call ratio
-
54%
-
Price per share
-
$3.11
-
Number of holders
-
106
-
Value change
-
+$4,287,026
-
Number of buys
-
53
-
Number of sells
-
39
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q1 2022
As of 31 Mar 2022,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,210,419 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, TCG Crossover Management, LLC, COMMODORE CAPITAL LP, BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BAKER BROS. ADVISORS LP, Nantahala Capital Management, LLC, Foresite Capital Management IV, LLC, and Altium Capital Management LP.
This page lists
106
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.